Sleep and Quality of Life Under Prolonged Release Oxycodone/Naloxone for Severe Restless Legs Syndrome: An Analysis of Secondary Efficacy Variables of a Double-Blind, Randomized, Placebo-Controlled Study with an Open-Label Extension

Eitemau Tebyg

• Intractable restless legs syndrome: role of prolonged-release oxycodone–naloxone
  gan: de Biase, Stefano, et al.
  Cyhoeddwyd: (2016)
• Long-term evaluation of combined prolonged-release oxycodone and naloxone in patients with moderate-to-severe chronic pain: pooled analysis of extension phases of two Phase III trials
  gan: Blagden, M, et al.
  Cyhoeddwyd: (2014)
• A randomized, double-blind, active-controlled, double-dummy, parallel-group study to determine the safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate/severe, chronic cancer pain
  gan: Ahmedzai, Sam H, et al.
  Cyhoeddwyd: (2012)
• Ropinirole in the treatment of restless legs syndrome: results from the TREAT RLS 1 study, a 12 week, randomised, placebo controlled study in 10 European countries
  gan: Trenkwalder, C, et al.
  Cyhoeddwyd: (2004)
• A phase III randomized controlled study on the efficacy and improved bowel function of prolonged‐release (PR) oxycodone‐naloxone (up to 160/80 mg daily) vs oxycodone PR
  gan: Dupoiron, D., et al.
  Cyhoeddwyd: (2017)